Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
General transcription factor IIIC subunit 3 (GTF3C3) is a core component of the transcription factor IIIC (TFIIIC) complex, a conserved eukaryotic six-subunit protein complex that is essential for the recruitment of the TFIIIB complex and for the initiation of RNA polymerase III (Pol III)-mediated transcription[1][2][6]. The TFIIIC complex functions by binding to specific promoter elements within small nuclear and cytoplasmic RNA genes, such as tRNA and 5S rRNA genes, facilitating pre-initiation complex assembly, and determining the transcription start site[1][6][7]. GTF3C3, as part of this complex, plays a vital role in these processes and also participates in chromatin organization and regulation of gene expression, including that of certain RNA polymerase II genes[1]. Biallelic variants in GTF3C3 have been associated with a neurodevelopmental disorder characterized by microcephaly, global developmental delay, intellectual disability, cerebellar atrophy, and seizures in humans and corresponding phenotypes in animal models, underscoring its critical role in neural development and gene regulation[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General transcription factor IIIC subunit 3 (GTF3C3).